Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7KI6 | 7KI6 | Structure of the HeV F glycoprotein in complex with the 1F5 neutralizing antibody | Fusion glycoprotein F0, 1F5 Fab light chain, 1F5 heavy chain |
| 7KIP | Q6Q1S2 | A 3.4 Angstrom cryo-EM structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles | Spike glycoprotein |
| 7KJ2 | P0DTC2 | SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound | Spike glycoprotein |
| 7KJ2 | Q9BYF1 | SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound | Spike glycoprotein |
| 7KJ3 | P0DTC2 | SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound | Spike glycoprotein |
| 7KJ3 | Q9BYF1 | SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound | Spike glycoprotein |
| 7KJ4 | P0DTC2 | SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound | Spike glycoprotein |
| 7KJ4 | Q9BYF1 | SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound | Spike glycoprotein |
| 7KJ5 | P0DTC2 | SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD up conformation | Spike glycoprotein |
| 7KJH | 7KJH | Plasmodium falciparum protein Pf12p bound to nanobody B9 | |
| 7KJH | C6KSX1 | Plasmodium falciparum protein Pf12p bound to nanobody B9 | |
| 7KJV | P03366 | Structure of HIV-1 reverse transcriptase initiation complex core | Reverse transcriptase/ribonuclease H, reverse transcriptase p51 subunit/RNA Complex |
| 7KK8 | Q6J5N4 | Fluoride channel Fluc-Ec2 mutant S81T with bromide | |
| 7KK8 | 7KK8 | Fluoride channel Fluc-Ec2 mutant S81T with bromide | |
| 7KK9 | Q6J5N4 | Fluoride channel Fluc-Ec2 mutant S81A/T82A with bromide | |
| 7KK9 | 7KK9 | Fluoride channel Fluc-Ec2 mutant S81A/T82A with bromide | |
| 7KKA | Q6J5N4 | Fluoride channel Fluc-Ec2 mutant S81A with bromide | |
| 7KKA | 7KKA | Fluoride channel Fluc-Ec2 mutant S81A with bromide | |
| 7KKB | Q6J5N4 | Fluoride channel Fluc-Ec2 mutant S81C with bromide | |
| 7KKB | 7KKB | Fluoride channel Fluc-Ec2 mutant S81C with bromide | |
| 7KKK | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody Nb6 |
| 7KKK | 7KKK | SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody Nb6 |
| 7KKL | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody mNb6 |
| 7KKL | 7KKL | SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody mNb6 |
| 7KKR | Q6J5N4 | Fluoride channel Fluc-Ec2 wild-type with bromide | |
| 7KKR | 7KKR | Fluoride channel Fluc-Ec2 wild-type with bromide | |
| 7KL9 | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4) | Spike glycoprotein, CTC-445.2 inhibitor |
| 7KL9 | 7KL9 | Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4) | Spike glycoprotein, CTC-445.2 inhibitor |
| 7KLC | Q2N0S5 | Crystal structure of M4H2K1 Fab bound to HIV-1 BG505 gp120 core and to 17b Fab | |
| 7KLC | 7KLC | Crystal structure of M4H2K1 Fab bound to HIV-1 BG505 gp120 core and to 17b Fab | |
| 7KLG | P0DTC2 | SARS-CoV-2 RBD in complex with Fab 15033 | |
| 7KLG | 7KLG | SARS-CoV-2 RBD in complex with Fab 15033 | |
| 7KLH | P0DTC2 | SARS-CoV-2 RBD in complex with Fab 15033-7 | |
| 7KLH | 7KLH | SARS-CoV-2 RBD in complex with Fab 15033-7 | |
| 7KM5 | P0DTC2 | Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1 | |
| 7KM5 | 7KM5 | Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1 | |
| 7KMA | Q14232 | Crystal structure of eif2Balpha with a ligand. | |
| 7KMB | Q9BYF1 | ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 7.4 | |
| 7KMB | P0DTC2 | ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 7.4 | |
| 7KMD | 7KMD | Crystal structure of a HIV-1 clade C isolate Du172.17 HR1.R4.664 Env trimer in complex with human Fabs PGT124 and 35O22 | |
| 7KMD | Q202J8 | Crystal structure of a HIV-1 clade C isolate Du172.17 HR1.R4.664 Env trimer in complex with human Fabs PGT124 and 35O22 | |
| 7KMF | Q13144 | Sugar phosphate activation of the stress sensor eIF2B | |
| 7KMF | P49770 | Sugar phosphate activation of the stress sensor eIF2B | |
| 7KMF | Q9UI10 | Sugar phosphate activation of the stress sensor eIF2B | |
| 7KMF | Q14232 | Sugar phosphate activation of the stress sensor eIF2B | |
| 7KMF | Q9NR50 | Sugar phosphate activation of the stress sensor eIF2B | |
| 7KMH | 7KMH | LY-CoV488 neutralizing antibody against SARS-CoV-2 | |
| 7KMH | P0DTC2 | LY-CoV488 neutralizing antibody against SARS-CoV-2 | |
| 7KMI | 7KMI | LY-CoV481 neutralizing antibody against SARS-CoV-2 | |
| 7KMI | P0DTC2 | LY-CoV481 neutralizing antibody against SARS-CoV-2 |
